Table 3.
Co-detections of HMPV and other respiratory virus in the study
| Groups | Co-infection viruses | NO. (%) |
|---|---|---|
| 2 viruses (n = 14) | HMPV + IFV | 4 (21.1) |
| HMPV + RSV | 3 (15.8) | |
| HMPV + HRV | 2 (10.5) | |
| HMPV + WUPyV | 2 (10.5) | |
| HMPV + ADV | 1 (5.3) | |
| HMPV + HCoV | 1 (5.3) | |
| HMPV + HBoV | 1 (5.3) | |
| 3 viruses (n = 3) | HMPV + IFV + RSV | 2 (10.5) |
| HMPV + HRV + WUPyV | 1 (5.3) | |
| 4 viruses (n = 1) | HMPV + HPIV + HCoV + ADV | 1 (5.3) |
| 5 viruses (n = 1) | HMPV + HPIV + RSV + ADV + WUPyV | 1 (5.3) |
ADV adenovirus, HBoV human bocavirus, HCoV human coronavirus (HKU1/229E/OC43/NL63), HPIV human parainfluenza virus 1–4, HRV human rhinovirus, IFV influenza virus A–C, RSV respiratory syncytial virus, WUPyV WU polyomavirus